Prognosis After Myocardial Infarction: Should we Still Use the Calculator or Just Measure a Biomarker?

pp. 1-2

Abstract

One of the great challenges in cardiology has been and continues to be to accurately establish the immediate and distant prognosis of patients with acute coronary syndrome (ACS). In the article published in this issue of the Journal by Kersten et al, the use of a troponin-derived score is proposed, using a score derived from the troponin value on admission as a multiple of the 99th percentile value, in order to balance the measurements of the different types of troponins. To validate this new score, they compare it with the performance of the GRACE and CRUSADE scores. The determination of troponin values at admission alone, which is almost universally used, can be used to estimate the patient's prognosis quite reliably.  Although troponin is a key biomarker in the assessment of patients with ACS, its interpretation should not be performed in isolation. Integration with other clinical factors remains essential for more accurate risk stratification.

How to cite this article:

Trivi M. Prognosis After Myocardial Infarction: Should we Still Use the Calculator or Just Measure a Biomarker? Rev Argent Cardiol 2025;93:1-2. https://doi.org/10.7775/rac.v93.i1.20860